Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eprotirome Add-on to Ezetimibe in Primary Hypercholesterolemia
NCT00677248Phase 2Completed
- Sponsor
- Karo Healthcare AB
- Start
- Apr 2008
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of eprotirome in hypercholesterolemia (4 arms), sponsored by Karo Healthcare AB. Primary endpoint: Low Density Lipoprotein Cholesterol at 10 weeks. Started Apr 2008; status: completed.
02
Drugs
eprotirome
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00677248.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00677248.